Corestreet Logo

Kalvista Pharmaceuticals Inc (KALV) Insider Trading

Total insider buys:
  • $47,413,163.82
Total insider sells:
  • $71,651,888.11
Most recent insider trade:
  • Feb. 23, 2026
Most active insider trader:
  • Benjamin L Palleiko
Trader NameDateTitleAmountPriceTypeTotal Value
Feb. 23, 2026CEO10,034$15.57Sell$156,229.38
Feb. 23, 2026CFO1,767$15.57Sell$27,512.19
Feb. 23, 2026Insider3,975$15.57Sell$61,890.75
Feb. 23, 2026Insider5,354$15.57Sell$83,361.78
Feb. 18, 2026CEO1,038$15.00Sell$15,570.00
Feb. 18, 2026Insider1,163$15.00Sell$17,445.00
Feb. 12, 2026CEO3,354$15.70Sell$52,657.80
Sept. 8, 2025CEO7,294$15.84Sell$115,536.96
Aug. 25, 2025Insider1,480$13.42Sell$19,861.60
Aug. 25, 2025Insider2,336$13.42Sell$31,349.12
Aug. 22, 2025CEO10,940$13.22Sell$144,626.80
Aug. 22, 2025Insider1,864$13.22Sell$24,642.08
Aug. 22, 2025Insider2,942$13.22Sell$38,893.24
July 9, 2025CEO32,979$15.69Sell$517,440.51
June 9, 2025CEO7,169$14.50Sell$103,950.50
May 23, 2025Insider2,146$11.31Sell$24,271.26
May 19, 2025CEO3,808$11.84Sell$45,086.72
May 19, 2025Insider2,776$11.84Sell$32,867.84
April 9, 2025Major Shareholder25,000$9.42Buy$235,500.00
March 7, 2025CEO6,669$11.97Sell$79,827.93
Feb. 24, 2025Insider2,394$10.02Sell$23,987.88
Feb. 18, 2025CEO5,104$9.82Sell$50,121.28
Feb. 18, 2025Insider3,125$9.82Sell$30,687.50
Feb. 12, 2025Major Shareholder100,000$9.23Buy$923,000.00
Feb. 10, 2025Major Shareholder4,137$9.14Buy$37,812.18
Feb. 7, 2025Major Shareholder73,649$9.29Buy$684,199.21
Feb. 3, 2025Major Shareholder14,562$9.22Buy$134,261.64
Jan. 30, 2025Major Shareholder43,707$8.76Buy$382,873.32
Dec. 9, 2024CEO7,627$9.75Sell$74,363.25
Nov. 26, 2024Insider2,187$9.87Sell$21,585.69
Nov. 18, 2024CEO14,400$9.26Sell$133,344.00
Nov. 18, 2024Insider8,077$9.26Sell$74,793.02
Sept. 9, 2024CEO7,352$12.19Sell$89,620.88
Aug. 23, 2024Insider2,135$12.40Sell$26,474.00
Aug. 19, 2024Insider7,102$12.01Sell$85,295.02
Aug. 19, 2024CEO14,215$12.01Sell$170,722.15
June 7, 2024CEO7,465$11.53Sell$86,071.45
May 20, 2024Insider8,088$11.76Sell$95,114.88
May 20, 2024CEO21,959$11.76Sell$258,237.84
Feb. 20, 2024CEO24,888$14.11Sell$351,169.68
Feb. 20, 2024Insider28,288$14.07Sell$398,012.16
Feb. 20, 2024CFO22,802$14.11Sell$321,736.22
Feb. 8, 2024Major Shareholder29,747$14.70Buy$437,280.90
Feb. 6, 2024Major Shareholder4,474$14.74Buy$65,946.76
Jan. 29, 2024Major Shareholder80,600$14.22Buy$1,146,132.00
Jan. 26, 2024Major Shareholder4,174$12.98Buy$54,178.52
Jan. 24, 2024Major Shareholder20,686$12.44Buy$257,333.84
Jan. 22, 2024Major Shareholder67,546$12.55Buy$847,702.30
Jan. 18, 2024Major Shareholder39,680$12.51Buy$496,396.80
Jan. 16, 2024Major Shareholder19,599$12.73Buy$249,495.27
First«1 of 3»Last

  • Insiders are both buying and selling Kalvista Pharmaceuticals Inc stock.

  • The insider traders at Kalvista Pharmaceuticals Inc are: Benjamin L Palleiko, Thomas Andrew Crockett, Venrock Healthcare Capital Par, Christopher Yea, Paul K Audhya, Edward P Feener, Albert Cha, Svlsf Iv, Llc, Life Sciences Fund Iv (Gp) Sv, Holdings A/S Novo, Nicole Sweeny, Andreas Maetzel, David Renzi, Acmp Iv Llc, Daniel B Soland, Brian Piekos, Rajeev M Shah, and Michael David Smith

  • The most active insider trader at Kalvista Pharmaceuticals Inc is Benjamin L Palleiko with 24 trades.

  • Holdings A/S Novo has sold the most Kalvista Pharmaceuticals Inc stock with a total value of $54,105,299.11.

  • Albert Cha has bought the most Kalvista Pharmaceuticals Inc stock with a total value of $29,566,911.61.

  • The most recent insider trade for Kalvista Pharmaceuticals Inc was on Feb. 23, 2026.

  • The single biggest insider buy for Kalvista Pharmaceuticals Inc was from Albert Cha with a total value of $18,000,008.00 on Sept. 10, 2018.

  • The single biggest insider sell for Kalvista Pharmaceuticals Inc was from Holdings A/S Novo with a total value of $26,271,728.12 on Oct. 12, 2017.